Location History:
- Lesmo (Milan), IT (1979)
- Lesmo, IT (1980 - 1988)
Company Filing History:
Years Active: 1979-1988
Title: The Innovative Mind of Fernando Fussi
Introduction
Fernando Fussi is a distinguished inventor based in Lesmo, Italy, known for his significant contributions to the field of biochemistry and pharmaceuticals. With a total of five patents to his name, his work particularly focuses on the development of heparin-related compounds with enhanced therapeutic properties. Fussi's innovative approaches have established him as a notable figure in the pharmaceutical industry.
Latest Patents
One of Fernando Fussi's latest patents is for "Oligo-heteropolysaccharides having a heparin-like activity method." This invention discloses an oligo-heteropolysaccharide that exhibits strong activity against thrombotic syndromes. The preparation method involves using depolymerized heparin fractions, where active groups, especially sulfuric groups, are reconstituted through a reaction with sulfotrioxide of a nitrogenous organic base, such as pyridine and trimethylamine.
Another significant patent is titled "Process for obtaining low molecular weight heparins endowed with pharmacological and therapeutic properties of outstanding interest." This innovation outlines a method for obtaining low molecular weight heparins from standard heparin. The process is characterized by a series of defined steps that enhance the pharmacological effects of the resulting compounds.
Career Highlights
Fernando Fussi's career includes notable positions at leading companies in the pharmaceutical industry, such as Hepar Chimie S.A. and Hepar Industries, Inc. His work in these organizations has allowed him to push the boundaries of what is possible in heparin research and its applications in medicine. He has shown exceptional capability in transforming theoretical concepts into practical solutions, enhancing the efficacy of treatments for various health conditions.
Collaborations
Throughout his career, Fussi has collaborated with various professionals in the field, including the esteemed Gianfranco Fedeli. These partnerships have played a crucial role in fostering innovative research and advancing the development of new therapeutic agents.
Conclusion
With five patents and ongoing contributions to pharmaceutical science, Fernando Fussi remains a pivotal figure in the invention of heparin-based therapies. His work exemplifies innovation in tackling serious health challenges, reflecting his commitment to improving patient outcomes through scientific discovery. As he continues to develop new methodologies, the impact of his research is sure to resonate within the industry for years to come.